From: NEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targets
Name | Functions | Mechanisms | Potential drug targets | Refs |
---|---|---|---|---|
Smurf1 | Inhibits osteoblast differentiation | Degrades BMP/Smad signaling pathway molecules | miR-195-5p, miR-25, miR-503, miR-19b-3p, miR-672-5p, miR-15b, GapmeRs, B06 and B75 compunds, chalcone derivatives, LMCD1, melatonin | |
 |  | Ubiquitinates JunB |  |  |
 |  | Attenuates JNK activation |  |  |
Smurf2 | Inhibits osteoblast differentiation | Ubiquitinates receptor of BMP and TGF‑β signaling pathway | Hakai, serine/threonine protein kinase Akt, miR-590-5p, miR-19b, miR-130a, lncRNA RAD51-AS1, TRAF4 | |
WWP1 | Negatively regulates bone homeostasis | Ubiquitinates molecules in BMP and TGF‑β signaling pathway | siRNA/NP complexes, miR-19b-3p, miR-142-5p, C3A DNA aptamer | |
 |  | Repressed by Wnt/β-catenin signaling pathway | miR-19b | [85] |
 |  | Ubiquitinates JunB |  |  |
WWP2 | Positively regulates osteogenesis | Relieves autoinhibition | NDFIP1/2, Dvl2 | |
 |  | Enhances Runx2 transactivation |  |  |
ITCH | Bidirectionally regulates osteogenesis | Phosphorylates Dvl in Wnt/β signaling pathway | Circ-ITCH | [107] |
 |  | Degrades Smad1 in BMP signaling pathway |  |  |
 |  | Degrades JunB |  |  |
 |  | Deubiquitinates TRAF6 |  |  |
NEDD4 | Positively regulates osteogenesis | Degrades pSMAD1 | Unclear | Unclear |
NEDD4L | Bidirectionally regulates osteogenesis | HuR-mediated upregulation of NEDD4L | lncRNA SNHG14 | [117] |
 |  | miR-214-3p/NEDD4L pathway | MOP | [118] |
 |  | Degrades Smad2/3 and TβR-I receptor in BMP and TGF‑β pathway |  |  |
 |  | Activates Akt pathway |  |  |